Showing results (6691-6700 of 10,388) with videos related to

Sort By:
Pageof 1,039
Vaccines|November 11, 2022
The Correlated Beta Dose Optimisation Approach: Optimal Vaccine Dosing Using Mathematical Modelling and Adaptive Trial DesignJohn Benest, Sophie Rhodes, Thomas G Evans, et al.
Vaccines|November 11, 2022
Comparing the Immunogenicity and Protective Effects of Three MERS-CoV Inactivation Methods in MiceNayoung Kim, Tae-Young Lee, Hansaem Lee, et al.
Vaccines|November 11, 2022
The Advantage of Using Immunoinformatic Tools on Vaccine Design and Development for CoronavirusJazmín García-Machorro, Gema Lizbeth Ramírez-Salinas, Marlet Martinez-Archundia, et al.
Vaccines|November 11, 2022
Designing of Peptide Based Multi-Epitope Vaccine Construct against Gallbladder Cancer Using Immunoinformatics and Computational ApproachesMukhtar Ahmad Dar, Pawan Kumar, Prakash Kumar, et al.
Vaccines|November 11, 2022
Influenza A(H7N9) Pandemic Preparedness: Assessment of the Breadth of Heterologous Antibody Responses to Emerging Viruses from Multiple Pre-Pandemic Vaccines and Population ImmunityMin Z Levine, Crystal Holiday, Yaohui Bai, et al.
Vaccines|November 11, 2022
Geographic and Socioeconomic Inequalities in Delays in COVID-19 Vaccinations: A Cross-Sectional Study in IndonesiaHario Megatsari, Dian Kusuma, Ernawaty Ernawaty, et al.
Vaccines|November 11, 2022
Seroprevalence of Measles Antibodies in a Highly MMR-Vaccinated PopulationHuy Quang Quach, Inna G Ovsyannikova, Diane E Grill, et al.
Vaccines|November 11, 2022
Updating the National Antigen Bank in Korea: Protective Efficacy of Synthetic Vaccine Candidates against H5Nx Highly Pathogenic Avian Influenza Viruses Belonging to Clades 2.3.2.1 and 2.3.4.4Yong-Myung Kang, Hyun-Kyu Cho, Sung-Jun An, et al.
Vaccines|November 11, 2022
Recent Progress on Vaccines Produced in Transgenic PlantsGoabaone Gaobotse, Srividhya Venkataraman, Kamogelo M Mmereke, et al.
Vaccines|November 11, 2022
Efficacy, Immunogenicity, and Safety of the Two-Dose Schedules of TURKOVAC versus CoronaVac in Healthy Subjects: A Randomized, Observer-Blinded, Non-Inferiority Phase III TrialMine Durusu Tanriover, Ozlem Altuntas Aydin, Rahmet Guner, et al.
Pageof 1,039